Home > Healthcare > Analytical Instruments > Molecular Analysis > Protein Purification & Isolation Market
Based on technology, the protein purification & isolation market is divided into preparative chromatography, ultrafiltration, precipitation, electrophoresis, western blotting, dialysis & diafiltration, and centrifugation. Among the technologies, preparative chromatography segment dominated the global market with market share of 29.5% in 2022. This technology allows selective capture and purification of target proteins based on specific interactions and helps to obtain purified protein with minimal interference from other molecules. For research and therapeutic proteins needs to be in highly pure form. This technology facilitates in achieving high levels of purity by effectively separating the target protein from contaminants and impurities. Due to its ability to provide high purity, selectivity, scalability, and reproducibility it offers a robust and efficient approach for obtaining purified proteins.
Based on product, the global protein purification & isolation market is segmented into consumables and instruments. The consumables segment is sub-segmented into protein purification kits, reagents, prepared columns, protein purification resins, magnetic beads, and other consumables. The magnetic beads segment is further sub-segmented into tagged magnetic beads and non-tagged magnetic beads.
In 2022, the consumables segment accounted for highest business share of 62.9%. Consumables such as kits, reagents, columns, resins are essential for performing chromatography techniques to purify and isolate proteins. Among the consumables segment, the protein purification kits accounted for highest market share as it simplifies the workflow, reduces the risk of cross-contamination, and enhances process efficiency. These kits are valuable in high-throughput processes or when working with multiple samples simultaneously.
Based on application, the global protein purification & isolation market is categorized into protein-protein interaction studies, drug screening, biomarker discovery, target identification, disease diagnostics & monitoring, and protein therapeutics. The protein-protein interaction studies held a significant share in 2022 and is expected to grow with a CGAR of 10.6% during the forecast period. The protein purification provides a controlled environment for studying protein-protein interaction. It enables accurate characterization of binding affinities and kinetics. The increasing adoption of this technique for obtaining highly purified proteins and increasing research studies related to structural protein are driving the growth of this segment.
Based on end-user, the protein purification & isolation market is classified into academic medical institutes, pharmaceutical & biotechnology companies, hospitals & diagnostics centers, and contract research organizations (CROs). The academic medical institutes accounted for highest market share in 2022 and is expected to reach USD 3.4 billion. The academic institutes are hubs for fundamental scientific research. The protein purification and isolation are essential process for such research institutes for understanding the structure, function, and interactions of proteins, that underlies different biological processes. During the forecast period, the contract research organizations are expected to witness growth at highest CAGR as CROs conduct precise research and development for pharmaceutical companies and increasing number of preclinical trials for drug development outsourced by the companies.
The north American protein purification and isolation market is expected to grow at CAGR of 10.3% over the forecast timeframe. North America has highly advance research and academic institutes which heavily rely on protein purification and isolation techniques. Addition this region has robust biotechnology and pharmaceutical industry which increases the demand for protein purification and isolation. Moreover, the supportive regulatory agencies, strong research, and academic institutes, increasing number of CROs, increasing demand for biologics and increasing clinical trials and drug development are collectively contributing to the growth of this market.